Four early-stage companies, including one making its first foray into the U.S. market, are settling in at the University City Science Center's Port Business Incubator.
CETICS Healthcare Technologies is a medical device company based in Germany. With its analysis technology and digitalization of sample profiles, the company's products drastically simplify how in-vitro diagnostics are used, opening new application areas in quality control, chemical stability testing, toxicology, and process optimization and control.
In Philadelphia, the company is launching a new product for genotoxicity testing. The TOXXs Analyzer is an automated method for fast quantification of DNA strand breaks and DNA repair capacities.
In the longer term, CETICS is developing a new generation of breakthrough in-vitro diagnostic products known as “Spectral Biomarkers” that can provide early, non-invasive diagnoses of Alzheimer Disease, prostate cancer and liver fibrosis.
HaRo Pharmaceutical, another new Port company, is conducting research and development focused on the treatment of high-risk neuroblastoma, funded by the National Cancer Institute (NCI). HaRo was the only small molecule therapeutic company — out of 75 startups nationwide — admitted to the Innovation Corps Team Training Pilot Program (ICORPS), an NCI/National Institutes of Health-sponsored intensive commercial development course.
Hyalo Technologies is a biotech and pharmaceutical company developing an innovative nanotechnology drug delivery system that promises to drastically reduce systemic side effects and increase patient compliance. Potential applications include cancer, pain management, wound healing and dermatology.
Legal Science Partners (LSP), spun out of Temple University's Beasley School of Law in 2013, builds tools for the legal profession. LSP's knowledge management platform, The Monocle, allows easy, low-cost access to legal information across jurisdictions and topics. Meanwhile, products such as LawAtlas.org and Workbench convert unstructured legal text into structured question-and-answer formats.
LSP is currently building custom platforms in particular areas of law such as Prescription Drug Overdose Prevention Laws for the National Institute for Drug Abuse and Everytown for Gun Safety, and is planning to release a prototype in the coming weeks of its 50StatUS, which will include pay-per-use statutory data in the business law sector.
Source: Kristen Fitch, University City Science Center
Writer: Elise Vider
